Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Zulli

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Experimental Pathology|September 18, 2009
A physiologically relevant atherogenic diet causes severe endothelial dysfunction within 4 weeks in rabbitSudarshan Rai, David L Hare, Anthony Zulli
Heliyon|September 26, 2022
Cisplatin for cancer therapy and overcoming chemoresistanceRanmali Ranasinghe, Michael L Mathai, Anthony Zulli
Journal of Atherosclerosis and Thrombosis|August 2, 2012
Simvastatin reduces endothelial NOS: caveolin-1 ratio but not the phosphorylation status of eNOS in vivoRajneet Arora, David L Hare, Anthony Zulli
Histochemistry and Cell Biology|May 1, 2009
The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaquePeter J Wookey, Anthony Zulli, David L Hare
Current Medicinal Chemistry|April 17, 2015
NADPH oxidases and inflammatory bowel diseaseGiang Lam, Vasso Apostolopoulos, Anthony Zulli, et al.
Molecular Metabolism|March 8, 2021
Osteocalcin and vascular function: is there a cross-talk?Alexander Tacey, Alan Hayes, Anthony Zulli, et al.
Heliyon|January 22, 2025
Nanocarrier-mediated cancer therapy with cisplatin: <i>A meta-analysis with a promising new paradigm</i>Ranmali Ranasinghe, Michael Mathai, Mohammed Abdullah Alshawsh, et al.
Clinical and Experimental Pharmacology & Physiology|April 10, 2015
Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit modelRenee M Smith, Rudi Klein, Peter Kruzliak, et al.
Clinical and Experimental Pharmacology & Physiology|May 23, 2015
Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunctionRenee M Smith, Peter Kruzliak, Zuzana Adamcikova, et al.
Nutrients|July 29, 2023
Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular DysfunctionLaura Kate Gadanec, Ulf Andersson, Vasso Apostolopoulos, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Experimental Pathology|September 18, 2009
A physiologically relevant atherogenic diet causes severe endothelial dysfunction within 4 weeks in rabbitSudarshan Rai, David L Hare, Anthony Zulli
Heliyon|September 26, 2022
Cisplatin for cancer therapy and overcoming chemoresistanceRanmali Ranasinghe, Michael L Mathai, Anthony Zulli
Journal of Atherosclerosis and Thrombosis|August 2, 2012
Simvastatin reduces endothelial NOS: caveolin-1 ratio but not the phosphorylation status of eNOS in vivoRajneet Arora, David L Hare, Anthony Zulli
Histochemistry and Cell Biology|May 1, 2009
The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaquePeter J Wookey, Anthony Zulli, David L Hare
Current Medicinal Chemistry|April 17, 2015
NADPH oxidases and inflammatory bowel diseaseGiang Lam, Vasso Apostolopoulos, Anthony Zulli, et al.
Molecular Metabolism|March 8, 2021
Osteocalcin and vascular function: is there a cross-talk?Alexander Tacey, Alan Hayes, Anthony Zulli, et al.
Heliyon|January 22, 2025
Nanocarrier-mediated cancer therapy with cisplatin: <i>A meta-analysis with a promising new paradigm</i>Ranmali Ranasinghe, Michael Mathai, Mohammed Abdullah Alshawsh, et al.
Clinical and Experimental Pharmacology & Physiology|April 10, 2015
Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit modelRenee M Smith, Rudi Klein, Peter Kruzliak, et al.
Clinical and Experimental Pharmacology & Physiology|May 23, 2015
Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunctionRenee M Smith, Peter Kruzliak, Zuzana Adamcikova, et al.
Nutrients|July 29, 2023
Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular DysfunctionLaura Kate Gadanec, Ulf Andersson, Vasso Apostolopoulos, et al.
Pageof 11